News

Filter

Current filters:

capecitabine

1 to 9 of 175 results

India's Cipla cuts prices of three cancer drugs

12-11-2012

Following what Indian drugmaker Cipla (BSE: 500087) said was an "overwhelming response" on the price…

Asia-PacificcapecitabineCipladocetaxelerlotinibGenericsOncologyPatentsPfizerPharmaceuticalPricingSunitinib MalateSutent

Switzerland’s Roche eyes up China’s potential

02-03-2010

China’s economy is rocketing, with Gross Domestic Product expanding at a double-digit annual rate,…

Asia-PacificcapecitabineerlotinibFinancialHerceptinMarkets & MarketingPharmaceuticalRituxanrituximabRocheTarcevatrastuzumabXeloda

NICE rejects Roche’s bowel cancer drug Avastin for a second time

27-11-2009

Having given it the cold shoulder three years ago, Britain’s healthcare cost effectiveness watchdog…

AvastinbevacizumabcapecitabineEuropeHealthcareOncologyPharmaceuticalRocheXeloda

1 to 9 of 175 results

Back to top